Cresset Asset Management’s Definium Therapeutics DFTX Stock Holding History

Cresset Asset Management’s Portfolio DFTX Stock Details DFTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-154,498	Closed	-$565K	–	1957
2023 Q4	$565K	Sell	154,498 -2,426	-2%	-$7.3K	﹤0.01%	1169
2023 Q3	$491K	Sell	156,924 -2,575	-2%	-$10.6K	﹤0.01%	1188
2023 Q2	$569K	Buy	+159,499	New	+$550K	﹤0.01%	1215
2022 Q2	–	Sell	-6,740	Closed	-$112K	–	1037
2022 Q1	$112K	Sell	6,740 -6,667	-50%	-$116K	﹤0.01%	937
2021 Q4	$278K	Buy	+13,407	New	+$428K	﹤0.01%	914

Other funds holding DFTX

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Ally Bridge Group New York $124M AUM 249.88% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return